
FDA Accepts Epinephrine (Anaphylm) Sublingual Film NDA for Type 1 Allergic Reactions
Aquestive Therapeutics has announced that the US Food and Drug Administration (FDA) acceptance of the Company’s New Drug Application (NDA) for epinephrine (Anaphylm) sublingual film for the treatment of Type 1 allergic reactions, including anaphylaxis.1 …